Lara Yoon, MPH

Articles

November 13th 2018

Understanding and Improving Value Frameworks With Real-World Patient Outcomes

Anupam B. Jena, MD, PhD Jacquelyn W. Chou, MPP, MPL Lara Yoon, MPH Wade M. Aubry, MD Jan Berger, MD, MJ Wayne Burton, MD A. Mark Fendrick, MD Donna M. Fick, RN, PhD David Franklin, BA Rebecca Killion, MA Darius N. Lakdawalla, PhD Peter J. Neumann, ScD Kavita Patel, MD, MSHS John Yee, MD, MPH Brian Sakurada, PharmD Kristina Yu-Isenberg, PhD, MPH, RPh

New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.

August 10th 2018

Evaluating HCV Screening, Linkage to Care, and Treatment Across Insurers

Karen Mulligan, PhD Jeffrey Sullivan, MS Lara Yoon, MPH Jacki Chou, MPP, MPL Karen Van Nuys, PhD

An optimized hepatitis C virus screening and linkage-to-care process reduces the number of patients lost to follow-up and improves linkage to care for Medicare, Medicaid, and commercially insured patients.

July 13th 2018

Modeling the Impacts of Restrictive Formularies on Patients With HIV

James Baumgardner, PhD Caroline Huber, MPH Mina Kabiri, PhD Lara Yoon, MPH Jacki Chou, MPP, MPL John Romley, PhD

Constraining access to HIV regimens can have significant implications for patients. This study examined the economic and health impacts of restrictive HIV formulary designs.